Brought to you by 
Galderma S.A.
http://www.galderma.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Galderma S.A.
Nestle, Bullish On Palforzia, To Buy Remainder Of Aimmune
Since Palforzia likely will be the only peanut allergy drug on market for some time, Nestle announces it will pay about $2.6bn to acquire the 80% of Aimmune it doesn’t own.
Dermavant's Tapinarof Could Bring Innovation To Topical Psoriasis Market
CEO Todd Zavodnick said the non-steroidal topical cream is poised to become a blockbuster brand.
UK’s COVID-19 Ventilator Challenge Scores First Success
UK anesthesia products manufacturer Penlon has received UK regulatory approval for a new ventilator, having taken up the government’s Ventilator Challenge in response to the COVID-19 pandemic.
Smiths Medical Ramps Up ParaPAC Ventilator Production For UK Order Of 10,000 Units
Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
- Other Names / Subsidiaries
-
- CollaGenex Pharmaceuticals, Inc., Nestle S.A.
- Nestle Skin Health S.A.
- Spirig Pharma AG